Caspase 3 as a Novel Marker to Distinguish Chromophobe Renal Cell Carcinoma from Oncocytoma
Open Access
- 22 November 2018
- journal article
- research article
- Published by Springer Nature in Pathology and Oncology Research
- Vol. 25 (4) , 1519-1524
Abstract
Despite advances in our understanding of the biology of chromophobe renal cell carcinoma (ChRCC) and renal oncocytoma (RO), the differential diagnosis among these tumors remains one of the most problematic in renal pathology. Today, CK7 is the most recommended marker to distinguish these entities, however it appears insufficiently accurate by itself. This study aimed to find an easily accessible IHC stain that might out-compete CK7 in this field. Expressions of CK7, cyclin D1, p16, survivin, CD138, Ki-67 and caspase 3 (CASP3) were analyzed in a total of 27 cases (20 ROs and 7 ChRCCs). Immunoreactivity was assessed based on a combined score of the extent and intensity of staining. Compared to RO, a higher percentage of the total ChRCCs stained positive for CK7 (67% vs. 22%, respectively) and CASP3 (86% vs. 25%) (P < 0.005). The differences in staining with cyclin D1, p16, survivin, CD138 and Ki-67 turned out to be statistically insignificant in differentiating ChRCC from RO. CASP3 is a promising marker in distinguishing ChRCC from RO and may represent an alternative for CK7. Cyclin D1, p16, survivin, CD138 and Ki-67 cannot be used to distinguish these neoplasms.Keywords
This publication has 41 references indexed in Scilit:
- Utility of immunohistochemical analysis of KAI1, epithelial-specific antigen, and epithelial-related antigen for distinction of chromophobe renal cell carcinoma, an eosinophilic variant from renal oncocytomaMedical Molecular Morphology, 2012
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion SequencingNew England Journal of Medicine, 2012
- Cyclin D as a therapeutic target in cancerNature Reviews Cancer, 2011
- Caspase 3–mediated stimulation of tumor cell repopulation during cancer radiotherapyNature Medicine, 2011
- p16Ink4a overexpression in cancer: a tumor suppressor gene associated with senescence and high-grade tumorsOncogene, 2011
- Role of syndecan‐1 (CD138) in cell survival of human urothelial carcinomaCancer Science, 2009
- Useful markers for differential diagnosis of oncocytoma, chromophobe renal cell carcinoma and conventional renal cell carcinomaIndian Journal of Pathology and Microbiology, 2008
- Renal oncocytoma, yet another tumour that does not fit in the dualistic benign/malignant paradigm?Journal of Clinical Pathology, 2007
- Immunohistochemical Analysis for Cytokeratin 7, KIT, and PAX2American Journal of Clinical Pathology, 2007
- Caveolin-1 Immunohistochemical Analysis in Differentiating Chromophobe Renal Cell Carcinoma From Renal OncocytomaAmerican Journal of Clinical Pathology, 2006